Abstract
The dose-response relationship for apomorphine-induced stereotypy in dogs is presented. A minimum effective dose is 0.2 mg/kg i.v., but the fully developed syndrome requires 0.8 mg/kg i.v. The stereotyped behaviour following the supramaximal dose 1.6 mg/kg i.v., mainly consisting in an incessant running activity, is described in detail.
Antipsychotic neuroleptics were highly active inhibitors of the apomorphinestereotypy, whereas phenoxybenzamine, amitriptyline, anticholinergics, antihistaminics, metoclopramide and diazepam were without influence on the stereotypy. H 44/68 (α-methyltyrosine-methylester) potentiated the syndrome. In provoking stereotyped behaviour in the dog, apomorphine, as in other species, probably acts directly on dopamine receptors in the corpus striatum.
Accordingly two sites of action for apomorphine may exist in the dog, the trigger zone in the area postrema for emesis, and the neostriatum for stereotypy.
Similar content being viewed by others
References
Amsler, C.: BeitrÄge zur Pharmakologie des Gehirns. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.97, 1–14 (1923).
Andén, N.-E., Corrodi, H., Fuxe, K., Hökfelt, T.: Increased impulse flow in bulbospinal NA neurons by catecholamine receptor blocking agents. Europ. J. Pharmacol.2, 59–64 (1967b).
—, Rubenson, A., Fuxe, K., Hökfelt, T.: Evidence for dopamine receptor stimulation by apomorphine. J. Pharm. Pharmacol.19, 627–629 (1967a).
Bhargava, K. P., Chandra, O.: Antiemetic activity of phenothiazines in relation to their chemical structure. Brit. J. Pharmacol.21, 436–440 (1963).
Bolme, P., Fuxe, K.: Pharmacological studies on the hypotensive effects of clonidine. Europ. J. Pharmacol.13, 168–174 (1971).
Carlsson, A.: Recent studies on the mode of action of antidepressive drugs. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path.257, 115–117 (1967).
Cools, A. R.: The function of dopamine and its antagonism in the candate nucleus of cats in relation to the stereotyped behaviour. Arch. int. Pharmacodyn.194, 259–269 (1971).
Ernst, A. M.: Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats. Psychopharmacologia (Berl.)10, 316–323 (1967).
—, Smelik, P. G.: Site of action of dopamine and apomorphine on compulsive gnawing behaviour in rats. Experientia (Basel)22, 837–838 (1966).
Feser, A.: Die in neuester Zeit in Anwendung gekommenen Arzneimittel. Z. prakt. Vet.-Wiss.1, 302–306 (1873).
Fog, R., Randrup, A., Pakkenberg, H.: Intrastriatal injection of butyrophenones and oxypertine: neuroleptic effect in rats. Psychopharmacologia (Berl.)19, 224–230 (1971).
Hanson, L. C. F.: The disruption of conditioned avoidance response following selective depletion of brain catecholamines. Psychopharmacologia (Berl.)8, 100–110 (1965).
Janssen, R. A. J., Niemegeers, C. J. E., Schellekens, K. H. L.: Is it possible to predict the clinical effects of neuroleptic drugs from animal data ? Part II: “Neuroleptic activity spectra” for dogs. Arzneimittel-Forsch.15, 1196–1206 (1965).
— — —, Lenaerts, F. M.: Is it possible to predict the clinical effects of neuroleptic drugs from animal data ? Part IV: An improved experimental design for measuring the inhibitory effects of neuroleptic drugs on amphetamineor apomorphine-induced “chewing” and “agitation” in rats. Arzneimittel-Forsch.17, 841–854 (1967).
Justin-BesanÇon, J., Laville, C.: Action antiémétique du métoclopramide vis-à-vis de l'apomorphine et de l'hydergine. C. R. Soc. Biol. (Paris)158, 723–727 (1964).
Laffan, R. J., High, J. P., Burke, J. C.: The prolonged action of fluphenazine enanthate in oil after depot injection. Int. J. Neurol.1, 300–306 (1965).
Menge, H. G., Brand, U.: Untersuchungen über die Stereotypien nach Amphetamin und Apomorphin sowie deren pharmakologische Beeinflussung. Psychopharmacologia (Berl.)21, 212–228 (1971).
Nymark, M., Franck, K. F., Pedersen, V., Aalund, M., MØller Nielsen, I.: Pharmacology of flupenthixol-decanoate in oil. (In preparation.)
Pedersen, V.: Role of catecholamines in compulsive gnawing behaviour in mice. Brit. J. Pharmacol.34, 219 P (1968).
Randrup, A., Munkvad, I.: Behavioural stereotypies induced by pharmacological agents. Pharmakopsychiat. Neuro-Psychopharmak.1, 18–26 (1968).
Roos, B.-E.: Decrease in homovanillic acid as evidence for dopamine receptor stimulation by apomorphine in the neostriatum of the rat. J. Pharm. Pharmacol.21, 263–264 (1969).
Rossum, J. M. van, Janssen, P. A. J., Boissier, J. R., Julou, L., Loew, D. M., Nielsen, I. M., Munkvad, I., Randrup, A., Stille, G., Tedeschi, D. H.: Modern problems of pharmacopsychiatry. Pharmacology of neuroleptic drugs. Basel: S. Karger 1970.
Wang, S. C.: Perphenazin, a potent and effective antiemetic. J. Pharmacol. exp. Ther.128, 306–310 (1958).
—, Borrison, H. L.: The vomiting center: its destruction by radon implantation in dog medulla oblongata. Amer. J. Physiol.166, 712–717 (1951).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nymark, M. Apomorphine provoked stereotypy in the dog. Psychopharmacologia 26, 361–368 (1972). https://doi.org/10.1007/BF00421901
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00421901